NIOX Share Price Performance
Recent NIOX News & Updates
No updates
NIOX Group Plc Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Sep 30, 2025
- Earnings per share (EPS)
- 0.0081
- Gross Margin
- 72.25%
- Net Profit Margin
- 8.13%
- Debt/Equity Ratio
- 0%
NIOX Group Plc Competitors
About NIOX
- Founded
- 2006
- Employees
- 91
- CEO
- WebsiteView website
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
U.K. Market Performance
- 7 Days: 1.6%
- 3 Months: 7.6%
- 1 Year: 7.9%
- Year to Date: 8.1%
Over the last 7 days, the market has risen 1.6%, driven by gains of 5.8% in the Materials sector. In the last year, the market has climbed 7.9%. Looking forward, earnings are forecast to grow by 14% annually. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue readingLast Week
